1996PubMedRequires access

[Heparin as the cause of severe thrombosis].

Ulrich Abildgaard, Myhre Ho

Open publisher page 0 citations

Abstract

Heparin-induced thrombocytopenia with thrombosis occurs in one out of about 2,000 patients on heparin treatment for five days. The new thrombosis is often arterial and may carry a grave prognosis. If thrombocytopenia develops during heparin treatment, heparin must be discontinued immediately. Alternative antihrombotic medication should be considered. Organs is probably the best alternative. Vascular surgery can be considered. In order to reduce the risk of experiencing this serious complication, oral anticoagulation should be initiated rapidly after heparin therapy is started. Compared with standard heparin, low molecular weight heparin probably involves less risk of the patient developing thrombocytopenia and thrombosis.

About this research paper

What this paper is about

Heparin-induced thrombocytopenia with thrombosis occurs in one out of about 2,000 patients on heparin treatment for five days. The new thrombosis is often arterial and may carry a grave prognosis. If thrombocytopenia develops during heparin treatment, heparin must be discontinued immediately. Alternative antihrombotic medication should be considered. Organs is probably the best alternative. Vascular surgery can be considered. In order to reduce the risk of experiencing this serious complication, oral anticoagulation should be initiated rapidly after heparin therapy is started. Compared with standard heparin, low molecular weight heparin probably involves less risk of the patient developing thrombocytopenia and thrombosis.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Heparin-induced thrombocytopenia with thrombosis occurs in one out of about 2,000 patients on heparin treatment for five days. The new thrombosis is often arterial and may carry a grave prognosis. If thrombocytopenia develops during heparin treatment, heparin must be discontinued immediately. Alternative antihrombotic medication should be considered. Organs is probably the best alternative. Vascular surgery can be considered. In order to reduce the risk of experiencing this serious complication, oral anticoagulation should be initiated rapidly after heparin therapy is started. Compared with standard heparin, low molecular weight heparin probably involves less risk of the patient developing thrombocytopenia and thrombosis.

Key concepts: Heparin, Thrombosis, Medicine, Heparin-induced thrombocytopenia, Complication, Surgery, Low molecular weight heparin, Intensive care medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
[Heparin as the cause of severe thrombosis]. — Research Paper | ScholarLens